Benzinga | Jul 30, 2021 12:34PM EDT

Morgan Stanley Maintains Equal-Weight on Vertex Pharmaceuticals, Lowers Price Target to $202

Morgan Stanley maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Equal-Weight and lowers the price target from $205 to $202.